These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37002660)

  • 1. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.
    McGuinness HY; Gu W; Shi Y; Kobe B; Ve T
    Neuroscientist; 2024 Aug; 30(4):473-492. PubMed ID: 37002660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARM1 is a metabolic sensor activated by an increased NMN/NAD
    Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
    Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemical biology of NAD
    Icso JD; Thompson PR
    Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
    Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
    Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
    Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
    Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
    Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
    Elife; 2016 Oct; 5():. PubMed ID: 27735788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARM1 axon degeneration pathway: control of the NAD
    Figley MD; DiAntonio A
    Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
    Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
    Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
    Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
    Elife; 2017 Jan; 6():. PubMed ID: 28095293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
    Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
    Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
    Gerdts J; Summers DW; Milbrandt J; DiAntonio A
    Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
    Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
    Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
    Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
    Essuman K; Summers DW; Sasaki Y; Mao X; DiAntonio A; Milbrandt J
    Neuron; 2017 Mar; 93(6):1334-1343.e5. PubMed ID: 28334607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage depletion blocks congenital SARM1-dependent neuropathy.
    Dingwall CB; Strickland A; Yum SW; Yim AK; Zhu J; Wang PL; Yamada Y; Schmidt RE; Sasaki Y; Bloom AJ; DiAntonio A; Milbrandt J
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36287209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy.
    DiAntonio A
    Pain; 2019 May; 160 Suppl 1(Suppl 1):S17-S22. PubMed ID: 31008845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.